BioCorRx Inc

Change company Symbol lookup

Select an option...

BICX BioCorRx Inc

GWPAX American Funds Growth Portfolio Class A

LIXTW Lixte Biotechnology Holdings Equity Warrants Exp 1st Jan 2025 *W EXP 01/01/2025

ZIONP Zions Bancorporation NA

BLK BlackRock Inc

GTEH Gentech Holdings Inc

$SPCOMBULD S&P 1500 Building Products(Sub Ind)

KELYA Kelly Services Inc

SONY Sony Group Corp

BVNRY Bavarian Nordic A/S

Go

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The Company's BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. It is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX104. Its lead candidate, BICX101, is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. It is also developing an implantable naltrexone treatment, BICX104, a long-acting naltrexone implant that can last several months for the treatment of opioid dependence and alcohol use disorders. Its subsidiary is BioCorRx Pharmaceuticals, Inc.